Globalepolicy.org is a free to access global medical news service for the consumer, professional and researcher.
Our adviser: Drugs Infromation online


             
 

Background: A treatment algorithm and screening examination have been developed to guide patient management and prospectively determine potential for highly active individuals to succeed with nonoperative care after anterior cruciate ligament rupture.

Objective: To prospectively characterize and classify the entire population of highly active individuals over a 10-year period and provide final outcomes for individuals who elected nonoperative care.

Methods: Inclusion criteria included presentation within 7 months of the index injury and an International Knee Documentation Committee level I or II activity level before injury. Concomitant injury, unresolved impairments, and a screening examination were used as criteria to guide management and classify individuals as noncopers (poor potential) or potential copers (good potential) for nonoperative care.

Results: A total of 832 highly active patients with subacute anterior cruciate ligament tears were seen over the 10-year period; 315 had concomitant injuries, 87 had unresolved impairments, and 85 did not participate in the classification algorithm. The remaining 345 patients (216 men, 129 women) participated in the screening examination a mean of 6 weeks after the index injury. There were 199 subjects classified as noncopers and 146 as potential copers. Sixty-three of 88 potential copers successfully returned to preinjury activities without surgery, with 25 of these patients not undergoing anterior cruciate ligament reconstruction at the time of follow-up.

Conclusion: The classification algorithm is an effective tool for prospectively identifying individuals early after anterior cruciate ligament injury who want to pursue nonoperative care or must delay surgical intervention and have good potential to do so.



NAVIGATION


         

 

More and more people being cared for on ventilators are conscious during the treatment, but what is it like to be fully conscious without being able to communicate with the world around you? A thesis from the Sahlgrenska Academy at the University of Gothenburg, Sweden, has lifted the lid on a world of panic, breathlessness and unheard pain…

 

According to a study published online in Thorax, asthma patients can improve their quality of life and ease persistent asthma symptoms during daytime by using a simple device called Protexo, which filters airborne asthma triggers from the air during sleep…

 

The US Food and Drug Administration (FDA) confirmed that the Decemember 31st 2011 ban on Chlorofluorocarbon (CFC) based asthma inhalers will go into force. The ban is part of the Montreal Protocol on substances that deplete the Ozone Layer., which dates back to international agreements made in the late 1980s…

 

An easy-to-use device developed by a local biomedical company is providing relief to Buffalo-area patients suffering from chronic obstructive pulmonary disease (COPD), which includes chronic bronchitis and emphysema. The Lung Flute, one of Popular Science magazine’s best 100 innovations of 2009, is a hand-held device that employs sound-wave technology to break up mucus in the lungs…

 

Wheezy toddlers who have a sensitivity to house dust mites are more at risk of developing asthma by the age of 12, a University of Melbourne led study has shown. Children aged one two years with a family history of allergy, who had a positive skin prick test to house dust mites, had a higher risk of developing asthma later in life…

 

Surgeons at the University of Kentucky on Aug. 3 announced that they were among the first to use artificial-lung technology to demonstrate the feasibility of a lung transplant, using a device invented by two university faculty members, Dr. Joseph Zwischenberger and Dr. Dongfang Wang…

 

People who use a mist inhaler to deliver a drug widely prescribed in more than 55 countries to treat chronic obstructive pulmonary disease (COPD) may be 52 percent more likely to die, new Johns Hopkins-led research suggests…

 

An inhaler designed to help chronic bronchitis and emphysema sufferers breathe could be significantly increasing their risk of dying, according to new research by the University of East Anglia (UEA) and three US universities…

 

A mist inhaler used to deliver the drug tiotropium to patients with chronic obstructive pulmonary disease (COPD) may be linked to an increased risk of death, suggests a study published on bmj.com today. The findings add weight to recent safety concerns by regulatory agencies regarding the possibility of an increased mortality risk associated with this device…

 

Hospitals in Manchester and Glasgow in the UK have started treating asthma patients with a pioneering new non-drug treatment for asthma that uses radio waves to burn away muscle tissue blocking the airways in the lungs…




May 2012
Mon Tue Wed Thu Fri Sat Sun
« Apr    
 123456
78910111213
14151617181920
21222324252627
28293031